tiprankstipranks
Palisade Bio to present preclinical results for PALI-2108
PremiumThe FlyPalisade Bio to present preclinical results for PALI-2108
3M ago
Palisade Bio initiated with a Buy at Brookline
Premium
The Fly
Palisade Bio initiated with a Buy at Brookline
3M ago
Palisade Bio price target lowered to $8 from $22.50 at Maxim
Premium
The Fly
Palisade Bio price target lowered to $8 from $22.50 at Maxim
4M ago
Palisade Bio files to sell common stock, warrants, no amount given
PremiumThe FlyPalisade Bio files to sell common stock, warrants, no amount given
4M ago
Palisade Bio received No Objection Letter from Health Canada for Phase 1 study
Premium
The Fly
Palisade Bio received No Objection Letter from Health Canada for Phase 1 study
5M ago
Palisade Bio CEO Finley’s Revised Employment and Compensation Deal
Premium
Company Announcements
Palisade Bio CEO Finley’s Revised Employment and Compensation Deal
5M ago
Starbucks picks new CEO, Google unveils Pixel 9: Tuesday Buzz
PremiumThe FlyStarbucks picks new CEO, Google unveils Pixel 9: Tuesday Buzz
7M ago
Starbucks picks new CEO, Baxter divests Kidney Care segment: Morning Buzz
Premium
The Fly
Starbucks picks new CEO, Baxter divests Kidney Care segment: Morning Buzz
7M ago
Palisade Bio reports Q2 EPS ($3.32) vs ($7.93) last year
Premium
The Fly
Palisade Bio reports Q2 EPS ($3.32) vs ($7.93) last year
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100